Reifycs Inc. is currently privately financed enterprise, and looking for investor to expand our presence around the world. If you interested in our business, please contact us by following contact information. We will send you the detail of our business model and prospective business
Contact Inforamtion :
2006
May
10th :
Reifycs Inc. established (Capital Fund: 2 million JPY)
Jun
15th :
Issuance of 1st stock option
Sep
30th :
Allocation of new shares to a third party (Capital Fund: 17 million JPY)
Nov
11th :
Sign an exclusive patent license consent agreement with Medical ProteoScope Co., Ltd.
Dec
1st :
Issuance of 2nd stock option
Dec
25th :
Exertion of stock options (Capital Fund: 17.95 million JPY)
2007
Jan
16th :
Patent applied for oligosaccharide chain analysis method
Feb
26th :
Patent applied for biomolecule identification
May
1st :
Sign a consignment sales contract with Ceres Bioscience Inc.
Jun
4th :
Protein analysis software ProteomicSuite™ Basis released
Aug
30th :
Exertion of stock options (Capital Fund: 27.65 million JPY)
Sep
18th :
Reifycs ProteomicSuite™ Workstation released
Oct
5th :
Reifycs adopted by Innovation Project for Common Facility of Advanced Research
